Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
81.56
+1.56 (1.95%)
Aug 6, 2026, 9:50 AM EDT - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $766.86 million as of August 6, 2026. Its market cap has increased by 234.29% in one year.
Market Cap
766.86M
Enterprise Value
546.00M
1-Year Change
234.29%
Ranking
Category
Stock Price
$81.56
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $766.86M, an increase of 1,735.32%. That is a compound annual growth rate of 69.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 766.86M | 22.27% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 758.86M |
| Aclaris Therapeutics | 744.41M |
| SpyGlass Pharma | 743.89M |
| Monopar Therapeutics | 739.31M |
| Candel Therapeutics | 723.18M |
| Pharming Group | 718.94M |
| Phathom Pharmaceuticals | 713.28M |
| Oculis Holding AG | 709.56M |